Stay updated on FAP Combo Treatment Clinical Trial
Sign up to get notified when there's something new on the FAP Combo Treatment Clinical Trial page.

Latest updates to the FAP Combo Treatment Clinical Trial page
- Check6 days agoChange DetectedThe study record for the Phase III eflornithine and sulindac trial is available, including its design, eligibility criteria, locations, outcomes, results publications, and study documents.SummaryDifference73%

- Check13 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check20 days agoChange DetectedA sitewide notice announces an NIH transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.SummaryDifference1%

- Check27 days agoChange DetectedThe footer revision identifier was updated from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check34 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.0 to v3.7.1; the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe study content is no longer accessible due to a 403 Forbidden error. The header/navigation and footer remain, but the main study details are not retrievable on this page.SummaryDifference21%

Stay in the know with updates to FAP Combo Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FAP Combo Treatment Clinical Trial page.